Management of Joint Pain with Elevated Inflammatory Markers and Renal Impairment

Diagnostic Approach

The American College of Rheumatology recommends obtaining urinalysis immediately to assess for proteinuria, hematuria, and cellular casts, as these findings differentiate glomerulonephritis from other causes of renal failure 1, 2.
The European League Against Rheumatism suggests measuring serum albumin to assess for nephrotic syndrome, as hypoalbuminemia combined with inflammatory arthritis may indicate systemic vasculitis or lupus nephritis 1.
The American Society of Nephrology recommends ordering complete blood count with differential to evaluate for cytopenias that could suggest systemic autoimmune disease affecting both kidneys and joints 2, 3.
The National Kidney Foundation advises obtaining renal ultrasound to assess kidney size and rule out obstructive uropathy, as small kidneys indicate chronic disease while normal-sized kidneys suggest acute or subacute processes 1.

The American College of Rheumatology recommends holding all NSAIDs immediately as they are contraindicated with eGFR 52 mL/min and will worsen renal function 6, 4, 1.
The European League Against Rheumatism suggests initiating prednisone 10-20 mg daily as bridge therapy for symptomatic relief while completing diagnostic workup, as corticosteroids are safe in renal impairment 6, 4, 5.
The American Society of Nephrology recommends considering intra-articular corticosteroid injections for large joints if oligoarticular involvement is present, as this provides local relief without systemic medication burden 6, 4.

The National Kidney Foundation advises reassessing renal function within 48-72 hours after initiating any treatment, as worsening creatinine indicates need for urgent nephrology consultation 1.
The American College of Rheumatology recommends monitoring inflammatory markers (CRP, ESR) every 4-6 weeks after treatment initiation to assess response to therapy 6, 4, 2.
The European League Against Rheumatism suggests performing serial joint examinations to document improvement or progression of synovitis 6, 4.

The American Society of Nephrology warns against starting methotrexate without clarifying renal function, as it is renally cleared and can cause life-threatening toxicity with impaired kidney function 2, 7.
The National Kidney Foundation advises against using NSAIDs for symptomatic relief given the eGFR of 52 mL/min, as they will cause further renal deterioration and potentially precipitate acute kidney injury 6, 4, 1.